2026 Interim Report
Filed with HKEX · Stock code 2179 · · 102 pages · English and Chinese
Mr. XU Haoyu Executive Directors1 Dr. LIU Yong (General Manager) Ms. WANG Jing Non-executive Directors Dr. WANG Ruwei Dr. ZHANG Jiaxin Dr. ZHOU Hongbin Mr. HU Houwei Independent Non-executive Directors Dr. XIA Lijun Mr. LIANG Guodong Professor GAO Feng Professor YUEN Ming Fai COMPANY SECRETARY2 Ms. SUEN Ka Yan 董事 董事董事會主席兼非執行董事徐浩宇先生 執行董事1 劉勇博士(總經理)王靜女士 非執行董事 王如偉博士張佳鑫博士周宏斌博士胡厚偉先生 獨立非執行董事 夏立軍博士梁國棟先生G
Jiangsu Recbio Technology Co., Ltd. on 6ix
Earlier from Jiangsu Recbio Technology
- Jiangsu Recbio Technology Says New Drug Application For REC610 Shingles Vaccine Accepted By NMPA
- Jiangsu Recbio Technology Says Liu Yong Resigned As Chair
- Jiangsu Recbio Technology Says Li Bu Resigned As Executive Director
Later from Jiangsu Recbio Technology
All Jiangsu Recbio Technology news releasesFollow Jiangsu Recbio Technology into a list and get an email when it puts out news.
Follow Jiangsu Recbio Technology